Erman Akkuş

17PUBLICATIONS
72CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 10, 2026
Different Stage But Similar Survival in Hepatocellular Carcinoma: A Dilemma of Treatment Timing?

|Jun 29, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Mar 14, 2026
Immune Checkpoint Inhibitor-Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis.

Erman Akkus, Hatime Arzu Yaşar

|Feb 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study.

Enes Erul, Vilma Pacheco-Barcia, Ali Alkan

|Jan 09, 2026
Chemotherapy tolerance and continuity are prognostic for overall survival in patients with localized and advanced biliary tract cancer.

Erman Akkuş, Pınar Kubilay Tolunay, Elif Berna Köksoy

Pageof 3

Frequent Collaborators

3 joint publications

Enes Erul

2 joint publications

Yuksel Urun

2 joint publications

Mehmet Kayaalp

2 joint publications

Mustafa Gürbüz